Recon Technology (RCON) Prices $2.1M Registered Direct Offering

Recon Technology, Ltd. (NASDAQ: RCON) announced today it has entered into a securities purchase agreement with certain accredited investors on June 26, 2020 to purchase $2.1 million worth of its ordinary shares in a registered direct offering and warrants to purchase ordinary shares in a concurrent private placement.

Under the terms of the securities purchase agreement, the Company has agreed to sell 1.68 million ordinary shares. In a concurrent private placement, the Company has agreed to issue unregistered warrants to purchase up to 1.68 million ordinary shares. The warrants will be exercisable immediately upon the date of issuance and have an exercise price of $1.25. The warrants will expire 5.5 years from the date of issuance. The purchase price for one ordinary share and a corresponding warrant will be $1.25. In addition, the initial exercise price for previously issued unregistered warrants to purchase 911,112 ordinary shares has decreased from $2.25 per share to $1.25 per share. The gross proceeds to the Company from this registered direct offering and concurrent private placement are estimated to be $2.1 million before deducting the placement agent's fees and other estimated offering expenses, assuming there is no exercise of any of the warrants. The registered direct offering and concurrent private placement are expected to close on or about June 30, 2020, subject to the satisfaction of customary closing conditions.

Maxim Group LLC ("Maxim") is acting as sole placement agent in connection with this offering.

The Company intends to use the net proceeds from this offering for general corporate purposes.

You May Also Be Interested In

• INmune Bio (INMB) Prices 986K Share Offering at $9.84/sh
• Belite Bio (BLTE) Announces $25 Million Registered Direct Offering
• Century Communities (CCS) Files Mixed Shelf